期刊文献+

代谢综合征、胰岛素抵抗与非酒精性脂肪肝关系的临床研究 被引量:7

The Clinical Study-of Relationship between Insulin Resistance and NonAlcoholic Fatty Liver in Patients with Metabolic Syndrome
暂未订购
导出
摘要 目的 探讨代谢综合征(MS)、胰岛素抵抗(IR)与非酒精性脂肪肝(NAFLD)之间的关系。方法 将150例MS患者分为NAFLD组和无NAFLD组,对体重指数(BMI)、甘油三脂(TG)、总胆固醇(TC)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、空腹血(FBG)、餐后2小时血糖(2hBG)、空腹胰岛素(FINS)、餐后2小时胰岛素(2hINs)、糖化血红蛋白(HbA1c)及胰岛素抵抗指数(IRI)进行对照并分别与正常对照组比较。结果 MS并NAFLD组与无NAFLD组相比较,TG、LDL、FINS、2hINS、ISI有显著性差异(P<0.05)。结论 MS并NAFLD患者存在明显脂代谢紊乱及IR,提示IR在MS与NAFLD之间的发生和发展起着重要的作用. Objective To Study of relationship between insulin resistance and NonAlcoholic fatty liver in patients with metabolic syndrome(MS).Methods 150 patients with metabolic syndrome are divided into the NAFLD group and non-NAFLD group , mass index (BMI) ,triglycende (TG),total olesterol (TC),high density lipoprotein (HDL) ,Low density lipoprotein (LDL) ,Fastingblood sugar (FBG) ,after meal 2 blood sugar (2 hBG) ,fasting blood insulin (FINS) after meal 2 insulin (2 hINS) ,sugar Oxidize the hemoglobin (HbAlc) and insulin resistive index number (IRI) are detected and conpareed with control group. Results NAFLD group in metabolic syndrome compare with no NAFLD groupTG, LDL ,FINS ,2 hINSs ,ISis have to show the Obivous difference (P〈0. 05).Conclusion Compared with nonNAFLD group in metabolic syndrome present the obvious blood lipid metabolic disorder and insulin resistance ,and there is a hint that the IR in the MS and NAFLD of function of occurrcence and developing rising importance.
出处 《国际医药卫生导报》 2007年第4期38-41,共4页 International Medicine and Health Guidance News
关键词 代谢综合症 胰岛素抵抗 非酒精性脂肪肝 metabolic syndrome Insulin resistance NonAlcoholic Fatty liver
  • 相关文献

参考文献7

二级参考文献34

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2邓银泉,余永谱,李夏玉,朱肖鸿,韦思金.脂肪肝的患病与相关因素调查分析[J].浙江医学,1996,18(4):254-255. 被引量:8
  • 3[3]Marceau P,Biron S,Hould FS,et al.Liver pathology and metabolic syndrome X in severe obesity[J].J Clin Endocrinol Metab,1999,84(5):1513-1517.
  • 4[4]Lonardo A.Fatty liver and nonalcoholic steatohepatitis.Where do we stand and where are we going?[J].Dig Dis,1999,17(2):80-89.
  • 5[5]Shimomura I,Hammer RE,Ikemoto S,et al.Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy[J].Nature,1999,401(6748):73-76.
  • 6[6]Shimomura T,Hammer RE,Richardson JA,et al.Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue:model for congenital generalized lipodystrophy[J].Genes Dev,1998,12 (20):3182-3194.
  • 7[7]Hubler A,Abendroth K,Keiner T,et al.Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes C[J].Exp Clin Endocrinol Diabetes,1998,106(1):79-84.
  • 8[8]Wacharasindhu S,Veerakul K,Likitmaskul S,et al.Congenital generalized lipodystrophy,a case report[J].Southeast Asian J Trop Med Public Health,1995,26[Suppl 1]:44-46.
  • 9[9]Ibrahim KM,Nicola WC,Salama SH.Mechanism of insulin resistance and hyper-insulinemia in fatty liver[J].Boll Chim Farm,1996,135(9):528-540.
  • 10[10]Marchesini G,Brizi M,Morselli Labate AM,et al.Association of nonalcoholic fatty liver disease with insulin resistance[J].Am J Med,1999,107 (5):450-455.

共引文献58

同被引文献60

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部